Metastatic Bladder Cancer: Second-Line Treatment and Recommendations of the Genitourinary Tumor Division of the Galician Oncologic Society (SOG-GU).

about

Advances in urothelial bladder cancer immunotherapy, dawn of a new age of treatment.

P2860

Q38737781-70789D53-970B-4EEA-B01A-DD3B7969AB41

P2860

Metastatic Bladder Cancer: Second-Line Treatment and Recommendations of the Genitourinary Tumor Division of the Galician Oncologic Society (SOG-GU).

Item

http://www.wikidata.org/entity/Q38798645

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Metastatic Bladder Cancer: Sec ...... an Oncologic Society (SOG-GU).

@en

type

Item

label

Metastatic Bladder Cancer: Sec ...... an Oncologic Society (SOG-GU).

@en

prefLabel

Metastatic Bladder Cancer: Sec ...... an Oncologic Society (SOG-GU).

@en

P1476

Metastatic Bladder Cancer: Sec ...... an Oncologic Society (SOG-GU).

@en

P2093

Ana Medina

http://www.w3.org/2001/XMLSchema#string

Javier Afonso-Afonso

http://www.w3.org/2001/XMLSchema#string

Jorge García

http://www.w3.org/2001/XMLSchema#string

Lucia Santomé

http://www.w3.org/2001/XMLSchema#string

Martín Lázaro

http://www.w3.org/2001/XMLSchema#string

Ovidio Fernández-Calvo

http://www.w3.org/2001/XMLSchema#string

Sergio Vázquez Estévez

http://www.w3.org/2001/XMLSchema#string

Urbano Anido

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials

Comprehensive molecular characterization of urothelial bladder carcinoma

Anti-vascular effects of vinflunine in the MAC 15A transplantable adenocarcinoma model

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

Monotherapy with intravenous vinflunine in patients with advanced or metastatic urothelial cancer after failure of a platinum-containing regimen: a retrospective analysis of German routine data.

Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.

Randomised phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO Trial AB 20/99).

Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium.

P2888

s11912-016-0556-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-016-0556-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1021938347

http://www.w3.org/2001/XMLSchema#string

P698

27812861

http://www.w3.org/2001/XMLSchema#string

Metastatic Bladder Cancer: Second-Line Treatment and Recommendations of the Genitourinary Tumor Division of the Galician Oncologic Society (SOG-GU).

about

P2860

P2860

Metastatic Bladder Cancer: Second-Line Treatment and Recommendations of the Genitourinary Tumor Division of the Galician Oncologic Society (SOG-GU).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698